Low Grade Glioma: Clinical Trials

3 trials for Low Grade Glioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Active not recruiting 1, Completed 1, Recruiting 1

Follow Low Grade Glioma: new trials by email Literature Review of Low Grade Glioma trials Research Report on Low Grade Glioma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Biospecimen Collection, Carboplatin, Echocardiography Test - Low Grade Astrocytoma, Low Grade Glioma
Phase 3RecruitingNational Cancer Institute (NCI)1702020-01-312026-11-06
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Carboplatin, Magnetic Resonance Imaging, Quality-of-Life Assessment - Low Grade Glioma, Neurofibromatosis Type 1
Phase 3Active not recruitingNational Cancer Institute (NCI)1652020-01-152026-08-13
A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma
Carboplatin and Vincristine, Carboplatin - Low Grade Glioma
Phase 3CompletedAlicia Lenzen952015-03-012026-09-02

Narrower conditions

Neurofibromatosis 1 (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplastic Syndromes, Hereditary (1)  ·  Nerve Sheath Neoplasms (1)  ·  Nervous System Diseases (1)  ·  Neurocutaneous Syndromes (1)  ·  Neurodegenerative Diseases (1)  ·  Neurofibroma (1)  ·  Neurofibromatoses (1)  ·  Neuromuscular Diseases (1)  ·  Peripheral Nervous System Diseases (1)

Interventions

Carboplatin (3)  ·  Vincristine (3)  ·  Magnetic Resonance Spectroscopy (2)  ·  Specimen Handling (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Alicia Lenzen (1)

Countries

United States (3)  ·  Canada (2)  ·  Puerto Rico (2)

Top investigators

Alicia Lenzen, MD (1)  ·  Jason R Fangusaro (1)  ·  Peter M de Blank (1)

Results publications

PMID 33395032, PMID 32597469

NIH funding

U10CA180886 (2)